Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001636651-17-000001
Filing Date
2017-01-20
Accepted
2017-01-20 13:58:37
Documents
1
Effectiveness Date
2017-01-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9822
  Complete submission text file 0001636651-17-000001.txt   10889
Mailing Address 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY 10017
Business Address 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY 10017 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-278877 | Film No.: 17538261